Lang Brian Hung-Hin, Lo Chung-Yau, Chan Wai-Fan, Lam King-Yin, Wan Koon-Yat
Division of Endocrine Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong SAR, China.
Ann Surg. 2007 Mar;245(3):366-78. doi: 10.1097/01.sla.0000250445.92336.2a.
To find out the most predictive staging system for papillary thyroid carcinoma (PTC) currently available in the literature.
Various staging systems or risk group stratifications have been used extensively in the clinical management of patients with PTC, but the most predictive system for cancer-specific survival (CSS) based on distinct histologic types remains unclear.
Through a comprehensive MEDLINE search from 1965 to 2005, a total of 17 staging systems were found in the literature and 14 systems were applied to the 589 PTC patients managed at our institution from 1961 to 2001. CSS were calculated by Kaplan-Meier method and were compared by log-rank test. Using Cox proportional hazards analysis, the relative importance of each staging system in determining CSS was calculated by the proportion of variation (PVE).
All 14 staging systems significantly predicted CSS (P < 0.001). The 3 highest ranked staging systems by PVE were the Metastases, Age, Completeness of Resection, Invasion, Size (MACIS) (18.7) followed by the new AJCC/UICC 6th edition tumor, node, metastases (TNM) (17.9), and the European Organization for Research and Treatment of Cancer (EORTC) (16.6).
All of the currently available staging systems predicted CSS well in patients with PTC regardless of which histologic type from which they were derived. When predictability was measured by PVE, the MACIS system was the most predictive staging system and so should be the staging system of choice for PTC in the future.
找出目前文献中对甲状腺乳头状癌(PTC)最具预测性的分期系统。
各种分期系统或风险组分层已广泛应用于PTC患者的临床管理,但基于不同组织学类型的对癌症特异性生存(CSS)最具预测性的系统仍不明确。
通过对1965年至2005年的MEDLINE进行全面检索,在文献中发现了总共17种分期系统,并将其中14种系统应用于1961年至2001年在我们机构接受治疗的589例PTC患者。CSS采用Kaplan-Meier法计算,并通过对数秩检验进行比较。使用Cox比例风险分析,通过变异比例(PVE)计算每个分期系统在确定CSS中的相对重要性。
所有14种分期系统均能显著预测CSS(P < 0.001)。按PVE排名最高的3种分期系统依次为转移、年龄、切除完整性、侵犯、大小(MACIS)(18.7),其次是新的美国癌症联合委员会/国际抗癌联盟(AJCC/UICC)第6版肿瘤、淋巴结、转移(TNM)分期系统(17.9),以及欧洲癌症研究与治疗组织(EORTC)分期系统(16.6)。
目前所有可用的分期系统对PTC患者的CSS预测效果都很好,无论其源自何种组织学类型。当通过PVE衡量预测性时,MACIS系统是最具预测性的分期系统,因此应成为未来PTC分期系统的首选。